Raiffeisen Bank International’s Ocular Therapeutix OCUL Stock Holding History

Raiffeisen Bank International’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$703K	Buy	+95,000	New	+$905K	0.01%	426

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Raiffeisen Bank International's OCUL Position: Q1 2026 in Review

Raiffeisen Bank International opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 95,000 shares worth $703K. The stake represents 0.01% of the portfolio and ranks #426 among its holdings.

269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

Raiffeisen Bank International held 95,000 shares of Ocular Therapeutix worth $703K as of Q1 2026.
Ocular Therapeutix was a new Raiffeisen Bank International position in Q1 2026.
Ocular Therapeutix made up 0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #426 holding.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.